Forget Lilly and Novo: Pfizer Is Planning a Wave of Phase 3 Obesity Trials
The Motley Fool ·
Everyone is talking about the GLP-1 battle between Eli Lilly and Novo Nordisk, but Pfizer wants in on the fight, too.
Forget Lilly and Novo: Pfizer Is Planning a Wave of Phase 3 Obesity Trials
Everyone is talking about the GLP-1 battle between Eli Lilly and Novo Nordisk, but Pfizer wants in on the fight, too.
1 sources · 1 articles · updated 2026-11-07 21:15 UTC · business